新医改以来我国药品价格管理问题及对策研究

发布时间：2018-07-13 15:13

【摘要】：近年来,“看病贵、看病难”成为百姓呼声强烈的重要民生问题,其中药价虚高问题尤为突出。药品价格经过多轮治理,取得了一定成效,但没有从根本上解决药价虚高问题。2009年,中国启动了新一轮医疗卫生体制改革,提出了“有效减轻居民就医费用负担,切实缓解‘看病难、看病贵’”的目标。笔者旨在通过对新医改以来药品价格管理政策实施效果进行研究,试提出行之有效的解决对策,对解决药价虚高,促进医药行业健康发展,增强政府价格规制能力,提高社会公众福利,具有重要的理论和现实意义。本文分为五大部分。第一部分是前言,介绍了研究背景和意义,阐述了研究综述,主要运用了文献研究法、历史研究法等基本研究方法。第二部分是药品价格管理概述,厘清了药品价格管理的基本概念,分析了药品价格管理的理论依据,总结了药品价格管理的原则和国外药品价格管理的一些共同特点。第三部分是梳理了中国价格管理的历史演变,着重介绍了2009年新医改以来的药品价格管理措施和配套制度。第四部分是陈述新医改以来药品价格措施实施效果,通过对实施情况进行分析研判,发现药品价格管理措施对控制药价取得了一定成效,但仍存在着一些问题,如药品”降价死”现象依然存在、药品集中采购有一定水分、民营药店执行药品价格政策不理想等,并从药品审批、定价、流通、采购、报销等各个环节和政府投入、部门协作等方面深入查找政策效果执行偏差的原因。第五部分提出了加强我国药品价格管理的一些对策,包括完善药品定价机制、提高价格监管和服务水平、深化医疗保障制度改革、加强药品生产流通使用管理,同步跟进配套措施等。
[Abstract]:In recent years, "expensive to see a doctor, difficult to see a doctor" has become an important issue of people's livelihood. After many rounds of treatment, drug prices have achieved certain results, but they have not fundamentally solved the problem of false high drug prices. In 2009, China launched a new round of reform of the medical and health system, proposing that "effectively lighten the burden of residents' medical expenses." Effectively alleviate 'difficult to see a doctor, see a doctor expensive' the goal. Through the research on the effect of drug price management policy since the new medical reform, the author tries to put forward some effective countermeasures to solve the problem of false high drug price, promote the healthy development of pharmaceutical industry, and strengthen the government's ability of price regulation. It is of great theoretical and practical significance to improve the welfare of the public. This paper is divided into five parts. The first part is the preface, introduces the research background and significance, expounds the research summary, mainly uses the literature research method, the history research method and so on basic research method. The second part is an overview of drug price management, clarifies the basic concept of drug price management, analyzes the theoretical basis of drug price management, summarizes the principles of drug price management and some common characteristics of foreign drug price management. The third part is to comb the historical evolution of China's price management, focusing on the new medical reform in 2009 since the drug price management measures and supporting systems. The fourth part is to state the effect of the implementation of drug price measures since the new medical reform, through the analysis of the implementation of the situation, found that the drug price management measures to control drug prices have achieved some results, but there are still some problems. For example, the phenomenon of "price reduction and death" still exists, there is a certain amount of water in the centralized procurement of drugs, the implementation of drug price policies by private pharmacies is not ideal, and so on, and from the drug approval, pricing, circulation, procurement, reimbursement and other links and government input, Departmental collaboration and other aspects to find out the policy effect of the implementation of deviation reasons. The fifth part puts forward some countermeasures to strengthen the drug price management in China, including perfecting the drug pricing mechanism, improving the price supervision and service level, deepening the reform of the medical security system, strengthening the management of drug production, circulation and use. Synchronously follow up the supporting measures, etc.
【学位授予单位】：复旦大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：R95

【相似文献】